GGrantIndex
Sort

50,496 grants matching lung cancer

COPD cachexia: deciphering the impact of antioxidants, iron and mitochondrial function using 'omics approaches

$642,195
Merry-Lynn Noelle McDonald Donnelly · University Of Alabama At Birmingham · R01 · FY2023 · HL

Optimization of MeV FLASH radiotherapy for normal tissue preservation

$642,155
Brian William Pogue · Dartmouth College · U01 · FY2022 · CA

MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer

$642,150
Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2017 · CA

Promoting Equity of Cancer Screening and Follow-up for Lung Cancer

$642,126
Chyke Abadama Doubeni · Ohio State University · R01 · FY2024 · CA

Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

$642,088
University Of Colorado Denver · N01 · FY2008 · CA

Sequencing Familial Lung Cancer

$642,057
Christopher I. Amos · Baylor College Of Medicine · R01 · FY2023 · CA

Sequencing Familial Lung Cancer

$642,057
Christopher I. Amos · Baylor College Of Medicine · U01 · FY2022 · CA

Engineering synthetic feedback control in T cell signaling for anti-tumor immunity

$642,044
Hao Yuan Kueh · University Of Washington · R01 · FY2024 · CA

REGULATION OF MUCOUS CELL METAPLASIA IN ASTHMA

$642,029
Yohannes Tesfaigzi · Lovelace Biomedical & Environmental Research Institute · R01 · FY2010 · HL

Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation

$641,997
Katerina Abigail Politi · Yale University · R01 · FY2023 · CA

Multi-Modality Quantitiative Imaging for Evaluation of Response to Cancer Therapy

$641,994
Eric C. Frey · Johns Hopkins University · U01 · FY2014 · CA

Role of necrosis in the evolution of highly metastatic and chemo-resistant breast cancers

$641,961
Kevin Jon Cheung · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

National Lung Screening Trial (NLST)

$641,956
Paul Kvale · Henry Ford Health System · N01 · FY2010 · CA

Inflammation and cancer treatment

$641,901
David Wink · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

A Role for KSHV in the Pathogenesis of Malignancies

$641,796
Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA

Employing CRISPR inactivation screening and in vivo models towards improving treatments for SCLC

$641,606
David Macpherson · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA

Ibis T-6,000 Biosensor System

$641,500
Cynthia L Sears · Johns Hopkins University · S10 · FY2010 · RR

Mice with Functional Fluorescent Nicotinic Receptor Subunits

$641,495
Henry A. Lester · California Institute Of Technology · RC2 · FY2009 · DA

Therapeutic Targeting Mitochondrial C1 Metabolism

$641,436
Larry H. Matherly · Wayne State University · R01 · FY2021 · CA

Phenotypic marker-guided development of selective antimetastasis therapeutic leads

$641,429
Sui Huang · Northwestern University At Chicago · R01 · FY2025 · CA

Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma

$641,388
Marc Elliott Lenburg · Boston University Medical Campus · R01 · FY2025 · CA

Tumor Suppressor Gene Methylation in Lung Adenocarcinoma

$641,352
Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2007 · ES

Targeting GARP-TGFbeta for Immunotherapy of Non-Small Cell Lung Cancer

$641,336
Zihai Li · Ohio State University · R01 · FY2024 · CA

Development of lisinopril for post-exposure mitigation of late effects from a rad

$641,332
Meetha M Medhora · Medical College Of Wisconsin · U01 · FY2016 · AI

Theranostic Approach to Asthma Using Anti-Angiogenic Nanomedicine

$641,184
Gregory M Lanza · Washington University · R01 · FY2013 · HL